Our website is currently being updated and you may experience some limited functionality at this time.
ProAxsis received an Invest NI Grant for Research and Development, supporting the company to develop new products using its innovative ProteaseTag® technology. The grant is part financed under the European Union’s Investment for Growth and Jobs Programme for Northern Ireland. The project, entitled “The development of ProteaseTags® for deubiquitinases (DUBs): innovative tools for biomarker identification and drug discovery in oncology”, will be over the next 12 months and aims to allow the design and synthesis of peptide-based inhibitors for the DUBs family, implemented followed by an assessment of their incorporation in to prototype activity-based immunoassay formats. (June 2018)